Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -50,616 | -19,725 | -8,858 | -19,713 | -19,042 |
| Depreciation Amortization | 1,457 | 974 | 488 | 1,995 | 1,495 |
| Income taxes - deferred | N/A | N/A | N/A | 23 | N/A |
| Accounts receivable | -9,708 | 326 | -206 | -360 | -110 |
| Other Working Capital | -7,251 | 58 | 149 | -1,175 | -1,136 |
| Other Operating Activity | 49,861 | 7,815 | 3,298 | -3,076 | 2,008 |
| Operating Cash Flow | $-16,256 | $-10,552 | $-5,130 | $-22,307 | $-16,785 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,241 | -5,241 | 51 | 4,867 | 2,367 |
| PPE Investments | -251 | -66 | -40 | -241 | -220 |
| Purchase Sale Intangibles | 1,000 | 1,000 | N/A | 650 | 650 |
| Other Investing Activity | 1,000 | 1,000 | 0 | 650 | 650 |
| Investing Cash Flow | $-4,492 | $-4,308 | $11 | $5,276 | $2,797 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 48,170 | 19,567 | 19,561 | 5,325 | 1,226 |
| Financing Cash Flow | $48,170 | $19,567 | $19,561 | $5,325 | $1,226 |
| Exchange Rate Effect | 0 | -2 | -1 | 2 | 1 |
| Beginning Cash Position | 5,646 | 5,646 | 5,646 | 17,350 | 17,350 |
| End Cash Position | 33,067 | 10,352 | 20,087 | 5,646 | 4,589 |
| Net Cash Flow | $27,421 | $4,706 | $14,441 | $-11,704 | $-12,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,256 | -10,552 | -5,130 | -22,307 | -16,785 |
| Capital Expenditure | -251 | -66 | -40 | -241 | -220 |
| Free Cash Flow | -16,507 | -10,618 | -5,170 | -22,548 | -17,004 |